1. |
|
|
2. |
|
|
3. |
|
|
4. |
|
|
5. |
- Dunham, I, et al.
(author)
-
The DNA sequence of human chromosome 22
- 1999
-
In: Nature. - : Springer Science and Business Media LLC. - 0028-0836 .- 1476-4687. ; 402:6761, s. 489-495
-
Journal article (peer-reviewed)
|
|
6. |
|
|
7. |
|
|
8. |
|
|
9. |
|
|
10. |
- Wang, RQ, et al.
(author)
-
Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world study
- 2021
-
In: Future oncology (London, England). - : Future Medicine Ltd. - 1744-8301 .- 1479-6694. ; 17:8, s. 893-906
-
Journal article (peer-reviewed)abstract
- Aim: To develop and internally validate nomograms to predict the overall survival (OS) and the cancer-specific survival (CSS) of patients with epithelial ovarian cancer (EOC). Methods: A total of 9001 EOC patients diagnosed between 2010 and 2013 were randomly divided into the training (n = 6301) and validation (n = 2700) cohorts. Nomogram and bootstrap validation were used to assess the predictive values of the models, including discrimination, calibration and clinical benefit. Results: In the validation cohort, the concordance statistic values were 0.733 for OS and 0.747 for CSS. Calibration plots and decision curve analyses demonstrated moderate accuracy and clinical applicability. Conclusion: Nomograms were user-friendly tools for guiding clinical treatment and estimating prognosis.
|
|